NSEGeneral Updates3d ago · 11 Aug 2026, 02:51 pm
General Updates
Torrent Pharmaceuticals Limited · TORNTPHARM
✦ AI SummaryESG
Torrent Pharmaceuticals Limited has received an ESG rating of 70 from NSE Sustainability Ratings and Analytics Limited.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Torrent Pharmaceuticals Limited has informed the Exchange about General Updates
Attachments (1)
📄pdf
Download →
TORNTPHARM_11082026145119_ESG.pdf
View document text
11th August, 2026
The Dy. General Manager (Listing Dept.) The Manager – Listing Dept.,
BSE Limited., National Stock Exchange of India Ltd.,
Corporate Relationship Dept., Exchange Plaza, 5th Floor,
1st Floor, New Trading Ring, Plot No. C/1, G. Block,
P. J. Towers, Dalal Street, Fort, Bandra - Kurla Complex, Bandra (E),
Mumbai - 400 001 Mumbai – 400 051
(BSE Scrip Code: 500420) (NSE Scrip Code: TORNTPHARM)
Dear Sir,
Sub.: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015
Pursuant to the provisions of Regulation 30 read with Schedule III of the SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015 and the SEBI Master Circular No.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026, we hereby notify that
NSE Sustainability Ratings and Analytics Limited, a SEBI registered ESG Rating Provider, has
independently assigned the Environmental, Social, and Governance (ESG) Rating of 70 to the
Company.
Kindly take note of the above.
Thanking you,
Yours Sincerely,
For TORRENT PHARMACEUTICALS LIMITED
CHINTAN M. TRIVEDI
COMPANY SECRETARY
Email – investorservices@torrentpharma.com